Home Rejuvenation Technologies

Rejuvenation Technologies

In operation
-
Pharmaceutical R&D and Production
Basic
Enterprise Profile

Basic Information

Rejuvenation Technologies is a biotechnology company that has developed nucleotide-modified TERT mRNA to safely and rapidly extend telomeres. The company's extender encodes telomerase reverse transcriptase, which is delivered into cells to temporarily increase telomerase activity for telomere extension, thereby enhancing cellular proliferative capacity, enabling targeting of age-related diseases and conditions, including those affecting the liver, lungs, and immune system.
Rejuvenation Technologies, Inc.
Mountain View,California,United States of America
less than 15 people
January 01, 2016
info@rejuvenationtech.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Cell Technology
Concept
Immune System Diseases Therapeutic Products
Application Scenarios
Innovative Drugs Nucleic Acid Drugs